Medicared For All Logo

Irene Ghobrial MD in Boston, Massachusetts

Home Massachusetts Boston

Irene Ghobrial MD has Hematology/oncology as her primary medical specialty. Their primary office is: 450 Brookline Ave in Boston, Massachusetts.

They're a part of the: Dana-farber Cancer Institute, Inc. medical group which has around 542 members. You can call their office at - to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 1995 (around 29 years of experience). They are listed as doing telehealth appointments.


Irene Monir Shafick Ghobrial MD Office Phone and Directions

Irene Ghobrial MD
Dana-farber Cancer Institute, Inc.
450 Brookline Ave
Boston, Massachusetts 02215
-


Patient Ratings
Please rate your experience with Irene Ghobrial MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...


Enter a starting address:


Healthcare Info for Irene Ghobrial MD

Additional Medical Specialties Include:
MEDICAL ONCOLOGY

Medical School: Sorry, her university is not listed
Graduation Year: 1995
The Primary Medical Specialty for Irene Ghobrial MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 29
PAC (PECOS ID)#: 4183607187
NPI #: 1306871637
NPI Created On: 07/12/2006
NPI Last Updated Listed as: 07/08/2007
Primary Taxonomy Code: 207RX0202X
License Number:
226664
Listed Gender: Female

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Harvard Pilgrim Health Care Inc.
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. New patient office or other outpatient visit, typically 45 minutes
  2. Established patient office or other outpatient visit, typically 15 minutes
  3. Established patient office or other outpatient, visit typically 25 minutes
  4. Physician telephone patient service, 21-30 minutes of medical discussion

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $600

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 767768850

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: Immunology

Name of Drug #1: FREELITE


Payments Total: $1,240

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 787614433

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05


Payments Total: $1,860

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 787614439

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05


Payments Total: $1,240

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 787614449

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05


Payments Total: $1,240

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 787614555

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05


Payments Total: $1,263

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 788098439

Being Disputed:: No

Product Related: No


Payments Total: $1,010

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 788098441

Being Disputed:: No

Product Related: No


Payments Total: $2,550

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 802846963

Being Disputed:: No

Product Related: No


Payments Total: $35

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802988601

Being Disputed:: No

Product Related: No


Payments Total: $900

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783689325

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Hematology

Name of Drug #1: Pomalyst

Open Associated Drug #1: 59572-502-00


Hematology/oncology Professionals in Boston

330 Brookline Ave
Boston, MA
Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc

88 E Newton St
Boston, MA
Evans Medical Foundation Inc

1 Boston Medical Ctr Pl
Boston, MA
Evans Medical Foundation Inc

450 Brookline Ave
Boston, MA
Dana-farber Cancer Institute, Inc.

450 Brookline Ave
Boston, MA
Dana-farber Cancer Institute, Inc.

75 Francis St
Boston, MA
Dana-farber Cancer Institute, Inc.

Providers in Dana-farber Cancer Institute, Inc.

1.Gregory Abel

20 Prospect St
Milford Ma 01757-3042
Dana-farber Cancer Institute, Inc.
Medical Oncology

2.Gregory Abel

450 Brookline Ave
Boston Ma 02215-5418
Dana-farber Cancer Institute, Inc.
Medical Oncology

3.Janet Abrahm

75 Francis St
Boston Ma 02115-6110
Dana-farber Cancer Institute, Inc.
Internal Medicine

4.Janet Abrahm

450 Brookline Ave
Boston Ma 02215-5418
Dana-farber Cancer Institute, Inc.
Internal Medicine

5.Thomas Abrams Md

22 Patriot Pl
Foxborough Ma 02035-1375
Dana-farber Cancer Institute, Inc.
Medical Oncology

6.Thomas Abrams Md

75 Francis St
Boston Ma 02115-6110
Dana-farber Cancer Institute, Inc.
Medical Oncology

View all 542 members of Dana-farber Cancer Institute, Inc. medical group